AVR 0.61% $11.50 anteris technologies ltd

MST Access research report, page-18

  1. 2,432 Posts.
    lightbulb Created with Sketch. 392
    Hi D, the first bit I have mentioned already.

    But be wary of assumptions, ‘assumptions’ to date about this company have cost most RIs here dearly.
    ‘The fact they are still here’ comment is reassuring, that said what entity would sell out at the same time as another that is exiting?. Not suggesting they would, but would you ‘bet’ your house on it? Last example was of a ex BOD member who was adamant he was here for the duration, what made him change hIs mind?

    SIO absolutely needed to be on board for the most obvious of reasons. It would defy a dismal history of previous TT holders exiting.

    For reflection; IF SB was only in it for the Vaccine and SIO are at their limit of exposure then would the majority of the $8 options (SB & SIO) NOT be taken up?, to me it seems to defy logic, that scenario could possibly mean no flush of new funding from the most obvious of sources.
 
watchlist Created with Sketch. Add AVR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.